72 results on '"Silverman, Earl"'
Search Results
2. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
3. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study
4. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
5. Ghostbusting—taking the sheet off the ghost
6. Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus
7. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
8. Brief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood-Onset Systemic Lupus Erythematosus
9. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
10. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
11. A153: Long-term Outcomes of Childhood-Onset Systemic Lupus Erythematosus in Adulthood
12. A149: Does Prenatal Exposure to Antimalarial Decrease the Risk of Neonatal Lupus: a Bayesian Perspective
13. A153: Long-term Outcomes of Childhood-Onset Systemic Lupus Erythematosus in Adulthood
14. A149: Does Prenatal Exposure to Antimalarial Decrease the Risk of Neonatal Lupus: a Bayesian Perspective
15. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study
16. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus
17. Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.: 1597
18. Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients
19. The role of antimalarial agents in the treatment of SLE and lupus nephritis
20. Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients
21. Prevalence and burden of pediatric-onset systemic lupus erythematosus
22. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
23. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity
24. Predictors of Early Inactive Disease in a Juvenile Idiopathic Arthritis Cohort: Results of a Canadian Multicenter, Prospective Inception Cohort Study
25. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus
26. Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort
27. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups
28. Chondrodysplasia punctata associated with maternal autoimmune diseases: Expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases
29. Feasibility and Effectiveness of an Aerobic Exercise Program in Children With Fibromyalgia: Results of a Randomized Controlled Pilot Trial
30. Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study
31. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
32. Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: Comment on the article by Compeyrot-Lacassagne et al
33. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform
34. The Effects of Vigorous Exercise Training on Physical Function in Children With Arthritis: A Randomized, Controlled, Single-Blinded Trial
35. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
36. Prevalence and Etiology of Low Bone Mineral Density in Juvenile Systemic Lupus Erythematosus
37. Hydrocephalus and macrocephaly: New manifestations of neonatal lupus erythematosus
38. Pediatric systemic lupus erythematosus
39. Longitudinal Examination of Lipid Profiles in Pediatric Systemic Lupus Erythematosus
40. Leflunomide in juvenile idiopathic arthritis
41. MACROPHAGE ACTIVATION SYNDROME AS THE PRESENTING MANIFESTATION OF RHEUMATIC DISEASES IN CHILDHOOD
42. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus
43. Primary central nervous system vasculitis in children
44. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus
45. Angiography-Negative Primary Central Nervous System Vasculitis in Children: A Newly Recognized Inflammatory Central Nervous System Disease
46. Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis
47. RADIOGRAPHIC VERTEBRAL MORPHOLOGY: A DIAGNOSTIC TOOL IN PEDIATRIC OSTEOPOROSIS
48. Long-Term Open-Label Preliminary Study of the Safety and Efficacy of Leflunomide in Patients With Polyarticular-Course Juvenile Rheumatoid Arthritis
49. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
50. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.